HomeInsightsStock Comparison

Sanofi Consumer Healthcare India Ltd vs Shree Ganesh Remedies Ltd Stock Comparison

Sanofi Consumer Healthcare India Ltd vs Shree Ganesh Remedies Ltd Stock Comparison

Last Updated on: Jun 29, 2025

Key Highlights

  • The Latest Trading Price of Sanofi Consumer Healthcare India Ltd is ₹ 5016 as of 27 Jun 15:30.
  • The P/E Ratio of Sanofi Consumer Healthcare India Ltd is 0 as of March 2020 .The P/E Ratio of Shree Ganesh Remedies Ltd is 6.2 as of March 2020.
  • The Market Cap of Sanofi Consumer Healthcare India Ltd is ₹ 0 crore as of March 2020 .The Market Cap of Shree Ganesh Remedies Ltd is ₹ 65.04 crore as of March 2020.
  • The revenue of Sanofi Consumer Healthcare India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Shree Ganesh Remedies Ltd for the Mar '25 is ₹ 26.72 crore as compare to the Dec '24 revenue of ₹ 27.76 crore. This represent the decline of -3.75%.
  • The ebitda of Sanofi Consumer Healthcare India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Shree Ganesh Remedies Ltd for the Mar '25 is ₹ 12.16 crore as compare to the Dec '24 ebitda of ₹ 10.61 crore. This represent the growth of 14.61%.
  • The net profit of Sanofi Consumer Healthcare India Ltd changed from ₹ 0 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of 0.0% The net profit of Shree Ganesh Remedies Ltd changed from ₹ 12.59 crore to ₹ 6.59 crore over 5 quarters. This represents a CAGR of -40.42% .
  • The Dividend Payout of Sanofi Consumer Healthcare India Ltd changed from 6.06 % on December 2023 to 69.89 % on December 2024 . This represents a CAGR of 239.60% over 2 yearsThe Dividend Payout of Shree Ganesh Remedies Ltd changed from 13.99 % on March 2020 to 0 % on December 2024 . This represents a CAGR of -100.00% over 7 years.

Share Price

* All values are in Rupees

PE

Market Cap

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Sanofi Consumer Healthcare India Ltd

  • Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, pursuant to a Certificate of Incorporation, issued by the Registrar of Companies, Central Registration Centre.
  • Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.
  • In terms of the said Scheme, the Company allotted 23,030,622 Equity Shares to the eligible shareholders of Sanofi India Limited (SIL) upon the demerger.

About Shree Ganesh Remedies Ltd

  • Shree Ganesh Remedies Limited was originally incorporated as a Private Limited Company with the name 'Shree Ganesh Remedies Private Limited' at Ahmedabad, Gujarat on April 27, 1995.
  • Subsequently the Company was converted into a Public Limited and the name of the Company was changed to 'Shree Ganesh Remedies Limited' on July 28, 2017.
  • The Company, a part of Ganesh Group has carved for itself a niche in the industry of manufacturing pharmaceutical intermediates and fine chemicals. Shree Ganesh Remedies is a ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified Company and is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry.
  • The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral.

Sanofi Consumer Healthcare India Ltd News Hub

News

Sanofi Consumer reports 20% YoY fall in Q1 PAT to Rs 50 cr

Revenue from operations fell 22.11% YoY to Rs 172.60 crore in the quarter ended 31 March 2...

Read more

03 May 2025 15:12

News

Sanofi Consumer Healthcare India to convene board meeting

Sanofi Consumer Healthcare India will hold a meeting of the Board of Directors of the Comp...

Read more

26 Apr 2025 10:37

News

Sanofi Consumer Healthcare CFO Maithilee Mistry resigns

According to an exchange filing, Mistry has decided to resign to explore new opportunities...

Read more

07 Apr 2025 12:44

News

Sanofi Consumer Healthcare India AGM scheduled

Sanofi Consumer Healthcare India announced that the 2nd Annual General Meeting(AGM) of the...

Read more

26 Mar 2025 17:41

News

Board of Sanofi Consumer Healthcare India recommends final dividend

Sanofi Consumer Healthcare India announced that the Board of Directors of the Company at i...

Read more

21 Feb 2025 09:40

News

Sanofi Consumer posts PAT of Rs 46 crore in Q3

Total operating expenditure rose by 13.8% YoY to Rs 111.50 crore in Q3 FY25, due to higher...

Read more

21 Feb 2025 10:34

Shree Ganesh Remedies Ltd News Hub

News

Shree Ganesh Remedies schedules board meeting

Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 19 M...

Read more

12 May 2025 10:22

News

Shree Ganesh Remedies to table results

Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 5 Fe...

Read more

30 Jan 2025 11:37

News

Shree Ganesh Remedies to declare Quarterly Result

Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 29 O...

Read more

24 Oct 2024 13:40

News

Shree Ganesh Remedies AGM scheduled

Shree Ganesh Remedies announced that the 29th Annual General Meeting (AGM) of the company ...

Read more

30 Sep 2024 10:05

News

Shree Ganesh Remedies announces board meeting date

Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 28 S...

Read more

21 Sep 2024 10:01

News

Shree Ganesh Remedies announces board meeting date

Shree Ganesh Remedies will hold a meeting of the Board of Directors of the Company on 12 A...

Read more

08 Aug 2024 16:04

SWOT Analysis Of Shree Ganesh Remedies Ltd

Strength

4

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Sanofi Consumer Healthcare India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Shree Ganesh Remedies Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Sanofi Consumer Healthcare India Ltd and Shree Ganesh Remedies Ltd

Which company has a larger market capitalization, Sanofi Consumer Healthcare India Ltd or Shree Ganesh Remedies Ltd?

Market cap of Sanofi Consumer Healthcare India Ltd is 11,552 Cr while Market cap of Shree Ganesh Remedies Ltd is 772 Cr

What are the key factors driving the stock performance of Sanofi Consumer Healthcare India Ltd and Shree Ganesh Remedies Ltd?

The stock performance of Sanofi Consumer Healthcare India Ltd and Shree Ganesh Remedies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sanofi Consumer Healthcare India Ltd and Shree Ganesh Remedies Ltd?

As of June 29, 2025, the Sanofi Consumer Healthcare India Ltd stock price is INR ₹5016.2. On the other hand, Shree Ganesh Remedies Ltd stock price is INR ₹601.55.

How do dividend payouts of Sanofi Consumer Healthcare India Ltd and Shree Ganesh Remedies Ltd compare?

To compare the dividend payouts of Sanofi Consumer Healthcare India Ltd and Shree Ganesh Remedies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions